influenza vaccine + PCV13

This is a combination immunization regimen consisting of two separate vaccines administered during the same healthcare visit: - **Influenza vaccine** is an inactivated or live attenuated viral vaccine that stimulates the immune system to produce antibodies against influenza virus strains included in the formulation. It is used for the prevention of seasonal influenza. - **PCV13 (pneumococcal 13-valent conjugate vaccine)**, also known as Prevnar 13, is a conjugate bacterial vaccine containing polysaccharides from 13 serotypes of *Streptococcus pneumoniae* linked to a carrier protein (CRM197). It induces active immunity by stimulating antibody production against these pneumococcal serotypes, preventing invasive diseases such as pneumonia, meningitis, and bacteremia caused by these bacteria. These vaccines are often co-administered in clinical practice for comprehensive protection against both influenza viruses and pneumococcal disease—especially in older adults or those with certain risk factors. Each component works independently; they are not physically combined but given at different injection sites during the same visit[2][3][4].

Other names

influenza vaccine and pneumococcal 13-valent conjugate vaccineinfluenza vaccine and Prevnar 13